Wolska N, Rozalski M
Int J Mol Sci. 2019; 20(21).
PMID: 31684173
PMC: 6862090.
DOI: 10.3390/ijms20215475.
Sudo T, Ito H, Ozeki Y, Kimura Y
Br J Pharmacol. 2001; 133(8):1396-404.
PMID: 11498527
PMC: 1621157.
DOI: 10.1038/sj.bjp.0704204.
Heintzen M, Heidland U, Klimek W, Leschke M, Kelm M, Schwartzkopff B
Heart. 2000; 83(5):551-6.
PMID: 10768906
PMC: 1760836.
DOI: 10.1136/heart.83.5.551.
SALAMA S, Haslam R
Biochem J. 1984; 218(2):285-94.
PMID: 6324754
PMC: 1153340.
DOI: 10.1042/bj2180285.
Campbell I, Taylor K
Biochem J. 1982; 204(3):689-96.
PMID: 6289802
PMC: 1158408.
DOI: 10.1042/bj2040689.
Current issues in thrombosis prevention with antiplatelet drugs.
de Gaetano G, Cerletti C, Dejana E, Vermylen J
Drugs. 1986; 31(6):517-49.
PMID: 3525085
DOI: 10.2165/00003495-198631060-00004.
Detection of 23-27 kDa GTP-binding proteins in platelets and other cells.
Bhullar R, Haslam R
Biochem J. 1987; 245(2):617-20.
PMID: 3117049
PMC: 1148167.
DOI: 10.1042/bj2450617.
Actions of dipyridamole on endogenous and exogenous noradrenaline in the dog mesenteric vein.
Li Y, Zhang G, Suzuki H, Kuriyama H
Br J Pharmacol. 1991; 102(1):51-6.
PMID: 2043931
PMC: 1917873.
DOI: 10.1111/j.1476-5381.1991.tb12131.x.
Membrane changes during cartilage maturation. Increase in 5'-nucleotidase and decrease in adenosine inhibition of adenylate cyclase.
Rodan G, Bourret L, Cutler L
J Cell Biol. 1977; 72(2):493-501.
PMID: 833206
PMC: 2111015.
DOI: 10.1083/jcb.72.2.493.
Mechanism of platelet function with particular reference to the effects of drugs acting as inhibitors.
LUSCHER E
Agents Actions. 1978; 8(3):282-90.
PMID: 352114
DOI: 10.1007/BF01966616.
13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
Le Breton G, Venton D, Enke S, Halushka P
Proc Natl Acad Sci U S A. 1979; 76(8):4097-101.
PMID: 291066
PMC: 383985.
DOI: 10.1073/pnas.76.8.4097.
Two distinct adenosine-sensitive sites on adenylate cyclase.
Londos C, Wolff J
Proc Natl Acad Sci U S A. 1977; 74(12):5482-6.
PMID: 271970
PMC: 431772.
DOI: 10.1073/pnas.74.12.5482.
Conformational basis for the activation of adenylate cyclase by adenosine.
Miles D, Miles D, EYRING H
Proc Natl Acad Sci U S A. 1977; 74(6):2194-8.
PMID: 267918
PMC: 432135.
DOI: 10.1073/pnas.74.6.2194.
Regulation of adenylate cyclase by adenosine.
Fain J, Malbon C
Mol Cell Biochem. 1979; 25(3):143-69.
PMID: 225658
DOI: 10.1007/BF00235364.
Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam R, Davidson M, Desjardins J
Biochem J. 1978; 176(1):83-95.
PMID: 215136
PMC: 1186207.
DOI: 10.1042/bj1760083.
Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.
Londos C, Cooper D, Schlegel W, Rodbell M
Proc Natl Acad Sci U S A. 1978; 75(11):5362-6.
PMID: 214785
PMC: 392963.
DOI: 10.1073/pnas.75.11.5362.
Stimulatory and inhibitory effects of cyclic AMP on pancreatic glucagon release from monolayer cultures and the controlling role of calcium.
Wollheim C, Blondel B, Renold A, SHARP G
Diabetologia. 1976; 12(3):269-77.
PMID: 182608
DOI: 10.1007/BF00422095.
Specific binding of 3H-adenosine to rat brain membranes.
Schwabe U, Kiffe H, Puchstein C, Trost T
Naunyn Schmiedebergs Arch Pharmacol. 1979; 310(1):59-67.
PMID: 43480
DOI: 10.1007/BF00499875.
Adenosine effects upon transmitter release parameters in the Mg2+-paralyzed neuro-muscular junction of frog.
Branisteanu D, Haulica I, Proca B, Nhue B
Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(3):273-9.
PMID: 41193
DOI: 10.1007/BF00501393.
Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.
Jakobs K, Saur W, Schultz G
Naunyn Schmiedebergs Arch Pharmacol. 1978; 302(3):285-91.
PMID: 26887
DOI: 10.1007/BF00508297.
